Crixivan and Effusion - a phase IV clinical study of FDA data
Summary:
We study 8,145 people who take Crixivan (indinavir sulfate) or have Effusion. No report of Effusion is found in people who take Crixivan.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
What is Crixivan?
Crixivan has active ingredients of indinavir sulfate. eHealthMe is studying from 6,312 Crixivan users. Check the latest studies of Crixivan.
What is Effusion?
Effusion (an escape of fluid into a body cavity) is found to be associated with 334 drugs and 437 conditions by eHealthMe. Check the latest studies of Effusion.
No report is found.
Do you take Crixivan and have Effusion?
- Check whether Effusion is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Crixivan:
- Crixivan (6,312 reports)
Effusion treatments and more:
- Effusion (1,833 reports)
How severe was Effusion and when was it recovered:
Expand to all the drugs that have ingredients of indinavir sulfate:
Browse all side effects of Crixivan:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Effusion:
Browse all the conditions that are associated with Effusion:
How the study uses the data?
The study uses data from the FDA. It is based on indinavir sulfate (the active ingredients of Crixivan) and Crixivan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Asacol cause Hair Loss? - 5 seconds ago
- Quviviq and Can'T Stay Awake for Women aged 60+ - 17 seconds ago
- Quviviq and Can'T Stay Wake for Women aged 60+ - 18 seconds ago
- Quviviq and Sleepiness for Women aged 60+ - 18 seconds ago
- Quviviq and Sleepy for Women aged 60+ - 18 seconds ago
- Quviviq and Drowsiness, Hypersomnia, Sleepiness - During The Day, Somnolence for Women aged 60+ - 19 seconds ago
- Quviviq and Somnolence for Women aged 60+ - 19 seconds ago
- Quviviq and Sleepiness - During The Day for Women aged 60+ - 19 seconds ago
- Quviviq and Hypersomnia for Women aged 60+ - 19 seconds ago
- Quviviq and Drowsiness for Women aged 60+ - 20 seconds ago